Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study.
Richard Ofori-AsensoDanny LiewSamanta LalicMohsen MazidiDianna J MaglianoZanfina AdemiJ Simon BellJenni IlomakiPublished in: Advances in therapy (2019)
A considerable proportion of Australians prescribed SGLT2is were non-adherent or non-persistent. However, empagliflozin was associated with better adherence and persistence rates and a lower likelihood of switching compared with dapagliflozin.